Multiple and diverse consequences of inhibiting gastric acid secretion: remembering the bicentenary of William Prout's discovery

Affiliations

¹ Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK dmpritch@liverpool.ac.uk.
² Department of Gastroenterology, Kings College Hospital, London, UK.

Comment

D Mark Pritchard et al. Gut. 2024.

. 2024 May 10;73(6):1036.

doi: 10.1136/gutjnl-2023-330133.

¹ Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK dmpritch@liverpool.ac.uk.
² Department of Gastroenterology, Kings College Hospital, London, UK.

No abstract available

Keywords: ACID; GASTRIC NEOPLASIA; GASTRIN; HELICOBACTER PYLORI.

Conflict of interest statement

Competing interests: None declared.

Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching.
Lee SW, Ha EK, Yeniova AÖ, Moon SY, Kim SY, Koh HY, Yang JM, Jeong SJ, Moon SJ, Cho JY, Yoo IK, Yon DK. Lee SW, et al. Gut. 2021 Jan;70(1):76-84. doi: 10.1136/gutjnl-2020-322248. Epub 2020 Jul 30. Gut. 2021. PMID: 32732368
Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
Seo SI, Park CH, You SC, Kim JY, Lee KJ, Kim J, Kim Y, Yoo JJ, Seo WW, Lee HS, Shin WG. Seo SI, et al. Gut. 2021 Nov;70(11):2066-2075. doi: 10.1136/gutjnl-2020-323845. Epub 2021 May 11. Gut. 2021. PMID: 33975868
Proton pump inhibitors and risk of gastric cancer: population-based cohort study.
Abrahami D, McDonald EG, Schnitzer ME, Barkun AN, Suissa S, Azoulay L. Abrahami D, et al. Gut. 2022 Jan;71(1):16-24. doi: 10.1136/gutjnl-2021-325097. Epub 2021 Jul 5. Gut. 2022. PMID: 34226290